For 6 week old infants 👶 from the makers of #Gardasil, #Merck pharmaceuticals has a 15 valent pneumonia jab waiting in the wings for all of our children☠️
https://www.healio.com/news/primary-care/20220622/fda-approves-15valent-pneumococcal-vaccine-for-children
#Vaxneuvance #pneumoniavaccine
https://www.healio.com/news/primary-care/20220622/fda-approves-15valent-pneumococcal-vaccine-for-children
#Vaxneuvance #pneumoniavaccine
Healio News
FDA approves 15-valent pneumococcal vaccine for children
Merck announced Wednesday that the FDA approved an expanded indication for Vaxneuvance, the company’s 15-valent pneumococcal conjugate vaccine, to include its use in infants and children aged 6 weeks to 17 years.